相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Belzutifan: First Approval
Emma D. Deeks
DRUGS (2021)
Quantitative Proteomics Identifies Secreted Diagnostic Biomarkers as well as Tumor-Dependent Prognostic Targets for Clear Cell Renal Cell Carcinoma
Aydanur Senturk et al.
MOLECULAR CANCER RESEARCH (2021)
Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis
Toni K. Choueiri et al.
NATURE MEDICINE (2021)
The role of the extracellular matrix protein TGFBI in cancer
Armando Corona et al.
CELLULAR SIGNALLING (2021)
Clear cell renal cell carcinoma ontogeny and mechanisms of lethality
Eric Jonasch et al.
NATURE REVIEWS NEPHROLOGY (2021)
ProteomicsDB: a multi-omics and multi-organism resource for life science research
Patroklos Samaras et al.
NUCLEIC ACIDS RESEARCH (2020)
TBK1 Is a Synthetic Lethal Target in Cancer with VHL Loss
Lianxin Hu et al.
CANCER DISCOVERY (2020)
RUNX1 Is a Driver of Renal Cell Carcinoma Correlating with Clinical Outcome
Nicholas Rooney et al.
CANCER RESEARCH (2020)
Effective combinatorial immunotherapy for penile squamous cell carcinoma
Tianhe Huang et al.
NATURE COMMUNICATIONS (2020)
Genome-wide Screening Identifies SFMBT1 as an Oncogenic Driver in Cancer with VHL Loss
Xijuan Liu et al.
MOLECULAR CELL (2020)
Hypoxia-Induced Epithelial-Mesenchymal Transition in Cancers: HIF-1α and Beyond
Shing Yau Tam et al.
FRONTIERS IN ONCOLOGY (2020)
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
David A. Braun et al.
NATURE MEDICINE (2020)
Acetylated K676 TGFBIp as a severity diagnostic blood biomarker for SARS-CoV-2 pneumonia
Hee Ho Park et al.
SCIENCE ADVANCES (2020)
Interaction with p53 explains a pro-proliferative function for VHL in cancer
Adam Kinnaird et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2020)
Adenoviral delivery of VHL suppresses bone sarcoma cell growth through inhibition of Wnt/β-catenin signaling
Changbao Chen et al.
CANCER GENE THERAPY (2019)
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
David J. Clark et al.
CELL (2019)
Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53-deficient cancers to mTOR inhibition
Na Kong et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Restoring p53 in cancer: the promises and the challenges
Guillermina Lozano
JOURNAL OF MOLECULAR CELL BIOLOGY (2019)
VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma
Jing Zhang et al.
SCIENCE (2018)
NF-κB-Dependent Lymphoid Enhancer Co-option Promotes Renal Carcinoma Metastasis
Paulo Rodrigues et al.
CANCER DISCOVERY (2018)
BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation
Tianhong Pan et al.
NEOPLASIA (2018)
The Prognostic Role of the Non-Canonical Nuclear Factor-Kappa B Pathway in Renal Cell Carcinoma Patients
Joanne Lua et al.
UROLOGIA INTERNATIONALIS (2018)
Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA
Mohammad Ariful Islam et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes
T. H. Ho et al.
ANNALS OF ONCOLOGY (2017)
Ubiquitination and regulation of AURKA identifies a hypoxia-independent E3 ligase activity of VHL
E. Hasanov et al.
ONCOGENE (2017)
VHL deficiency augments anthracycline sensitivity of clear cell renal cell carcinomas by down-regulating ALDH2
Yao-Hui Gao et al.
NATURE COMMUNICATIONS (2017)
HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism
Weinan Du et al.
NATURE COMMUNICATIONS (2017)
The pVHL(172) isoform is not a tumor suppressor and up-regulates a subset of pro-tumorigenic genes including TGFB1 and MMP13
Pauline Hascoet et al.
ONCOTARGET (2017)
Renal cell carcinoma
James J. Hsieh et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
The non-canonical NF-κB pathway in immunity and inflammation
Shao-Cong Sun
NATURE REVIEWS IMMUNOLOGY (2017)
Systematic approaches to identify E3 ligase substrates
Mary Iconomou et al.
BIOCHEMICAL JOURNAL (2016)
Targeting renal cell carcinoma with a HIF-2 antagonist
Wenfang Chen et al.
NATURE (2016)
On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models
Hyejin Cho et al.
NATURE (2016)
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
Maxim V. Kuleshov et al.
NUCLEIC ACIDS RESEARCH (2016)
pVHL suppresses kinase activity of Akt in a proline-hydroxylation-dependent manner
Jianping Guo et al.
SCIENCE (2016)
CRISPR-Mediated VHL Knockout Generates an Improved Model for Metastatic Renal Cell Carcinoma
Shiruyeh Schokrpur et al.
SCIENTIFIC REPORTS (2016)
FunRich: An open access standalone functional enrichment and interaction network analysis tool
Mohashin Pathan et al.
PROTEOMICS (2015)
Identification and validation of TGFBI as a promising prognosis marker of clear cell renal cell carcinoma
Souhil Lebdai et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
VHL, the story of a tumour suppressor gene
Lucy Gossage et al.
NATURE REVIEWS CANCER (2015)
Loss of von Hippel-Lindau Protein (VHL) Increases Systemic Cholesterol Levels through Targeting Hypoxia-Inducible Factor 2α and Regulation of Bile Acid Homeostasis
Sadeesh K. Ramakrishnan et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
The MIntAct project-IntAct as a common curation platform for 11 molecular interaction databases
Sandra Orchard et al.
NUCLEIC ACIDS RESEARCH (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
Edward Y. Chen et al.
BMC BIOINFORMATICS (2013)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer
Sakari Vanharanta et al.
NATURE MEDICINE (2013)
Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target
Marco Gerlinger et al.
JOURNAL OF PATHOLOGY (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
TGFBI-promoted Adhesion, Migration and Invasion of Human Renal Cell Carcinoma Depends on Inactivation of von Hippel-Lindau Tumor Suppressor
Donghao Shang et al.
UROLOGY (2012)
HIF1 alpha and HIF2 alpha: sibling rivalry in hypoxic tumour growth and progression
Brian Keith et al.
NATURE REVIEWS CANCER (2012)
Von Hippel-Lindau gene product directs cytokinesis: a new tumor suppressor function
Sutapa Sinha et al.
JOURNAL OF CELL SCIENCE (2011)
Genetic and Functional Studies Implicate HIF1α as a 14q Kidney Cancer Suppressor Gene
Chuan Shen et al.
CANCER DISCOVERY (2011)
Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis
Xin Lu et al.
CLINICAL CANCER RESEARCH (2010)
Molecular Analysis of Tumor Margins by MALDI Mass Spectrometry in Renal Carcinoma
Stacey R. Oppenheimer et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Ubiquitin/SUMO Modification Regulates VHL Protein Stability and Nucleocytoplasmic Localization
Qiliang Cai et al.
PLOS ONE (2010)
HIF-2α deletion promotes Kras-driven lung tumor development
Jolly Mazumdar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Effects of HIF-1 alpha and HIF2 alpha on Growth andMetabolism of Clear-Cell Renal Cell Carcinoma 786-0 Xenografts
Swethajit Biswas et al.
JOURNAL OF ONCOLOGY (2010)
Grade-dependent Proteomics Characterization of Kidney Cancer
Bertrand Perroud et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
HIF2α inhibition promotes p53 pathway activity, tumor cell death, and radiation responses
Jessica A. Bertout et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Two novel VHL targets, TGFBl (BIGH3) and its transactivator KLF10, are up-regulated in renal clear cell carcinoma and other tumors
Sergey V. Ivanov et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Collagen matrix assembly is driven by the interaction of von Hippel-Lindau tumor suppressor protein with hydroxylated collagen IV alpha 2
G. Kurban et al.
ONCOGENE (2008)
A yeast two-hybrid system reconstituting substrate recognition of the von Hippel-Lindau tumor suppressor protein
Claudia Bex et al.
NUCLEIC ACIDS RESEARCH (2007)
pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-κB agonist Card9 by CK2
Haifeng Yang et al.
MOLECULAR CELL (2007)
Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations
Lianjie Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Loss of VHL confers hypoxia-inducible factor (HIF)-dependent resistance to vesicular stomatitis virus: Role of HIF in antiviral response
Irene I. L. Hwang et al.
JOURNAL OF VIROLOGY (2006)
Characterization of a von Hippel Lindau pathway involved in extracellular matrix remodeling, cell invasion, and angiogenesis
G Kurban et al.
CANCER RESEARCH (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma
RR Raval et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Mechanism of von Hippel-Lindau protein-mediated suppression of nuclear factor kappa B activity
JB An et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
oPOSSUM: identification of over-represented transcription factor binding sites in co-expressed genes
SJH Sui et al.
NUCLEIC ACIDS RESEARCH (2005)
Mechanism of processing of the NF-κB2 p100 precursor:: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCFβ-TrCP ubiquitin ligase
RE Amir et al.
ONCOGENE (2004)
A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging
V Ponomarev et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
von Hippel-Lindau protein binds hyperphosphorylated large subunit of RNA polymerase II through a proline hydroxylation motif and targets it for ubiquitination
AV Kuznetsova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Regression of solid tumors by engineered overexpression of von Hippel-Lindau tumor suppressor protein and antisense hypoxia-inducible factor-1 alpha
X Sun et al.
GENE THERAPY (2003)
Control of Smad7 stability by competition between acetylation and ubiquitination
E Grönroos et al.
MOLECULAR CELL (2002)
Role of exon 2-encoded β-domain of the von Hippel-Lindau tumor suppressor protein
ME Bonicalzi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
